SNO 2018: Pembrolizumab Demonstrates Immune Response in Recurrent Glioblastoma
Results of two trials point to immune response.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Results of two trials point to immune response.
Only registered members have full access to PracticeUpdate content.